Regulation · on the rundown Thursday, June 11, 2026
UK regulator approves daily Wegovy pill for weight loss
Covered by 3 outlets. They ran 2 distinct reports. First reported by investegate.co.uk at 16:00 UTC on June 11, 2026.
- outlets3
- distinct reports2
- first to latest report0 h
- names in it2
Who reported it, and when?
| Time | Report | Run by |
|---|---|---|
| Jun 11 16:00 | Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP - 1 weight - loss pill approved in the united kingdom | Company Announcement | |
| Jun 11 16:00 | Daily Wegovy pill for weight loss approved by regulator in united kingdom first |
|
Who was named?
- Novo Nordisk 47 events
- Wegovy Pill
More news naming Novo Nordisk
- Sep 22 · Biotech GLP-1 drugmakers face lawsuits over alleged sudden vision loss risk 4
- Sep 9 · Biotech Study links semaglutide to fewer asthma attacks, COPD flare-ups 2
- Sep 1 · Healthcare channelnewsasia.com: “Oncology firm Novocure says cyberattack exposed US patient records” 2
- Aug 26 · Cyber Boston Scientific says cybersecurity incident disrupted global order processing, shipping 4
- Aug 3 · Healthcare 933thedrive.com: “Eli Lilly to offer early access to next - gen obesity drug to some patients” 2
- Jul 21 · Legal Novo Nordisk sues Eli Lilly over alleged false advertising 5
Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).